Intranasal granisetron and nasal applicator

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 8827946
APP PUB NO 20110045088A1
SERIAL NO

12848850

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Formulations and methods of manufacture are provided for granisetron dry powder compositions suitable for intranasal administration. Also provided are methods of use for preventing or controlling emesis and other diseases and disorders and devices, compositions, and methods for nasal delivery of therapeutic formulations. Devices for delivery of dry powder formulations are also provided. Devices can be single-use devices.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
SHIN NIPPON BIOMEDICAL LABORATORIES LTD2438 MIYANOURA-CHO KAGOSHIMA-SHI KAGOSHIMA 8911394 ?8911394

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Haruta, Shunji Kagoshima, JP 29 371
Nagata, Ryoichi Kagoshima, JP 26 339
Tsutsui, Tatsuo Yokohama, JP 16 218

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Mar 9, 2026
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00